Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
2.

Modulation of Na, K-ATPase activity by immunoglobulins--III. Influence of an ATPase activity regulating agent "Marina" on Na, K-ATPase activity in patients with various chronic disturbances.

Ponomarenko E, Pokrotnieks J, Jirgensons J, Seleznevs J, Danilans A, Shubnikova N, Kalvins I.

Zhonghua Yi Xue Za Zhi (Taipei). 2001 Nov;64(11):617-20.

PMID:
11853215
3.

Changes in membrane fluidity induced by tryptophan and its metabolites.

Rudzite V, Jurika E, Jirgensons J.

Adv Exp Med Biol. 1999;467:353-67.

PMID:
10721077
4.

[Peculiarities of nicotinic acid formation in coronary heart disease with special reference to heart arrhythmias].

Rudzite V, Jirgensons J, Jurika E, Sileniece G, Zirne R, Jirgensone S.

Z Gesamte Inn Med. 1988 Feb 1;43(3):60-5. German.

PMID:
3369217

Supplemental Content

Loading ...
Write to the Help Desk